In the News

NHS launches World’s Largest Trial of Cancer Blood Test

The National Health Service (NHS) in the United Kingdom has announced the world’s largest trial of GRAIL’s Galleri blood test, which was developed to detect more than 50 types of cancer before symptoms appear. The NHS hopes to recruit 140,000 volunteers across the UK to...

Aetion and Quinten Health partner to use AI and RWE to reduce research timelines

Aetion and Quinten Health have partnered up to better provide a range of real-world evidence (RWE) generation products and services by reducing complexity, increasing efficiency, and supporting rapid turnaround times to improve patient outcomes. Aetion Co-Founder and President Jeremy Rassen said the partnership will allow for...

Xealth Secures $24 Million in Series B Funding to Accelerate Digital Health

Xealth has announced an additional $24 million in Series B funding, bringing its total raised to $52.6 million. The funding round was led by Advocate Aurora Enterprises, with additional participation from seven health systems--Banner Health, ChristianaCare, Cone Health, Memorial Hermann, Nebraska Medicine, Novant Health, and...

Oncology Analytics Announces Rebrand to OncoHealth

Oncology Analytics has changed its name to OncoHealth, a forward-looking rebrand for the company’s vision of the future and its focus on helping people through their cancer journey. "OncoHealth represents our evolution of better aligning the way we serve clients and the way our clients access...

New multi-cancer early detection blood test study opens

The University of Oxford has opened a new study, which will trial a new multi-cancer early detection (MCED) blood test for early detection of more than 50 types of cancer. The study, SYMPLIFY, is also open at Oxford University Hospitals (OUH) and already includes more...